CytoMed Therapeutics Limited's total assets for Q4 2025 were $7.98M, an increase of 21.49% from the previous quarter. GDTC total liabilities were $1.13M for the fiscal quarter, a 26.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.